LABRAILE MCCOY: Open Payments
NPI 1639626591 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,260 in 56 payments from 19 companies in 2025. Trend: 2023 $1,544 · 2024 $1,228 · 2025 $1,260
Food & beverage: $1,260
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $293 |
| Abbott Laboratories | 5 | $113 |
| Exact Sciences Corporation | 6 | $106 |
| SHIELD THERAPEUTICS INC | 4 | $104 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $97 |
| GlaxoSmithKline, LLC. | 4 | $69 |
| ABBVIE INC. | 4 | $66 |
| PFIZER INC. | 3 | $66 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Lundbeck LLC | 2 | $53 |
Products named: Wegovy, REXULTI, FREESTYLE LIBRE 3, Cologuard Collection Kit, ACCRUFER, Kerendia, Ozempic, SHINGRIX.
Industry payments across GA — which companies pay providers there.
